Email bookmark
Font : A-A+

Drug information on Femistra (1 mg) (Anastrozole) from Zydus Takeda Healthcare Pvt. Ltd.

Femistra (1 mg)

Zydus Takeda Healthcare Pvt. Ltd.
Generic : Anastrozole
10 Tablets

Drug Name : Anastrozole

Anastrozole(rimidex) generic Femistra (1 mg) is a non-steroidal inhibitor used with other treatments, such as surgery or radiation, to treat early breast cancer in women who have experienced menopause. Femistra (1 mg) is also used in women, who have experienced menopause, as a first treatment of breast cancer that has spread within the breast or to other areas of the body. It is also used to treat breast cancer in women whose breast cancer has worsened after taking tamoxifen (Nolvadex).
More Info about Anastrozole

Written & Compiled by Anushta Chandrapalan, M.Sc  | Medically Reviewed by The Medindia Medical Review Team on February, 2, 2017
Medindia currently has information on 3080 generic drugs and 110,061 brands that have their prices listed. New drugs with their prices are listed as and when they get approved by the drug controller. Please do write to us ( if a drug is missing from our comprehensive drug price list.

Medical Condition(s) for which Femistra (1 mg) may be prescribed

Side effects of Femistra (1 mg)

  Heart: Widening of blood vessels, hypertension, sudden cardiac death, blood clot in veins and insufficient blood supply to brain.

  Central Nervous System: Lack of energy, mood disturbances, headache, depression, sleeplessness, dizziness, fainting, abnormal sensations, anxiety, increased tightness of muscle, slurred speech and fatigue.

  Skin: Rash, sweating, redness of the skin, pain, burning, or tingling in the hands or feet, mucous membrane infection, hair thinning.

  Eye and ENT: Inflammation of pharynx, difficulty swallowing or breathing, persistent cough and clouding of eye lenses.

  Gastrointestinal: Stomach disturbances, nausea, loss of appetite, vomiting, abdominal pain, constipation, diarrhea, indigestion, gastrointestinal disorder and dry mouth.

  Genitourinary: Breast pain, urinary tract infection, inflammation of vagina, breast neoplasm, vaginal bleeding, whitish or yellowish vaginal discharge and vaginal dryness.

  Blood-Lymphatic: Lymph nodes swelling, decrease in hemoglobin, and white blood cells.

  Liver: Increased level of liver enzymes and jaundice.

  Hypersensitivity: Allergic reactions including hypersensitivity reaction, rapid swelling of the dermis and skin rash.

  Metabolic-Nutritional: Edema, high blood cholesterol, increased levels of alkaline phosphatases and weight loss.

  Musculoskeletal: Inflammation of joints, joint pain, back pain, bone pain, an increased risk of fracture, pelvic pain and muscle pain.

  Respiratory:Difficulty in breathing, increased cough, sinus or sinusitis and inflammation of bronchus.

  Miscellaneous: Bone weakness, hot flashes, pain, accidental injury, infection, chest pain, flu syndrome, cyst, neoplasm and tumor flare.

Dosage & When it is to be taken (Indications)

Adjuvant treatment in early breast cancer; Advanced or locally advanced breast cancer in postmenopausal women: 1 mg/day.

How to use Femistra (1 mg)?

This medication is available in the form of tablets to take by mouth once a day, with or without food.

When is Femistra (1 mg) not to be taken? (Contraindications)

Contraindicated in pregnant women, premenopausal women, patients who are experienced with hypersensitivity to any components.

Warnings and Precautions for Femistra (1 mg)

Caution should be exercised in patients with history of moderate or severe liver impairment, excess fat, children.

• Be sure to mention any of the following: medications that contain estrogen such as hormone replacement therapy (HRT) and hormonal contraceptives (birth control pills, patches, rings, and injections); raloxifene (Evista); and tamoxifen (Nolvadex) before starting therapy with Anastrozole.

• It may cause dizziness. Do not drive a car or operate machinery while driving this medication.

• Avoid alcohol consumption.

• Do the lab test for menopause if status is doubtful.

• Bone mass density (bone mineral density) test should be conducted at the start of the therapy and at regular intervals thereafter.

Other Precautions for Femistra (1 mg)

Monitor cholesterol levels and bone mineral density periodically.

Storage Conditions for Femistra (1 mg)

Oral: Store at 20-25°C. Store it in airtight container.

Disclaimer : updates the prices regularly, however despite that there may be discrepancies in the prices displayed. This can be due to many reasons including -
  • Difference in GST/local taxes
  • Change in price by the company
  • Updation of information may not have happened at the right time
For the above reasons Medindia cannot be held liable for any action taken based on the information provided by its website. The purpose of this website is to only provide the initial guidance and it does not intend to replace professional medical opinion in any manner whatsoever.

Buy Medicines (Drug) at Concessional Price from India
Substitutes for Femistra (1 mg)

View all

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.